Willowbrook Hepatitis Study

The Willowbrook hepatitis studies were a series of nontherapeutic experiments conducted from 1956 to 1971 at the Willowbrook State School, a chronically overcrowded New York state institution for children with intellectual disabilities on Staten Island, in which researchers deliberately infected newly admitted children with live hepatitis virus to study the disease and test a candidate preventive treatment. It is one of the cases named in Henry Beecher’s influential 1966 critique of U.S. research ethics, and it remains a standard reference point — alongside the Nuremberg Code and the Tuskegee Syphilis Study — for why research involving children and institutionalized, cognitively impaired subjects requires protections beyond ordinary informed consent.

What the researchers did

Dr. Saul Krugman of New York University, working with Dr. Robert W. McCollum of Yale University, led a program of hepatitis research at Willowbrook that ran for roughly fifteen years. The team fed healthy children extracts prepared from the stool of infected patients, and in later phases injected serum containing the virus, deliberately producing infection in subjects who did not otherwise have the disease. The stated scientific goal was to distinguish infectious (fecal-oral, later understood as hepatitis A) from serum (bloodborne, later understood as hepatitis B) hepatitis, characterize each disease’s course, and evaluate whether gamma globulin — a blood product containing antibodies — could prevent or reduce the severity of infection. The work did produce genuine scientific findings used in later hepatitis and gamma-globulin research, which is part of what made the case a harder ethical test than research with no scientific value at all: real knowledge gained through subjects who could not meaningfully consent to producing it.

How consent was obtained — and why it is contested

Willowbrook operated far beyond its intended capacity, and admission waiting lists were long. Investigators and later critics both describe a de facto arrangement in which prompt admission to the institution’s regular wards was more readily available to families who agreed to enroll their child in the hepatitis research ward, which — researchers argued — was actually cleaner and better staffed than the general wards. Researchers defended deliberately infecting the children on the grounds that hepatitis was already endemic in the institution’s crowded, unsanitary conditions, so admitted children stood a substantial chance of contracting it regardless of the study. That argument does not resolve the core consent problem: it does not establish that parents, faced with a de facto choice between an overcrowded general ward and a study ward, were exercising free, uncoerced consent to a nontherapeutic experiment on their child, nor does it address the separate ethical question of whether deliberately infecting a child with a disease is justified because that child might otherwise acquire it by accident.

Beecher’s 1966 critique and the broader reform context

In 1966, Harvard anesthesiologist Henry K. Beecher published “Ethics and Clinical Research” in the New England Journal of Medicine, reviewing 22 published studies — drawn from mainstream, well-regarded U.S. research institutions — that he judged to involve serious, unaddressed ethical problems, most centrally inadequate or absent informed consent. The Willowbrook hepatitis studies were among the cases Beecher’s article discussed. The article is widely credited, alongside the Nuremberg Code and the ongoing, still-secret Tuskegee Syphilis Study, as part of the pressure that built through the 1960s and early 1970s toward codified U.S. human-subjects protections. Unlike Tuskegee’s 1972 public exposure, which is the direct, documented trigger for the National Research Act of 1974 and the Belmont Report, Willowbrook’s role was more diffuse — it was one of the documented cases that made the broader pattern Beecher described impossible to dismiss as isolated or historical, and it is cited specifically, then and now, for what it demonstrates about consent involving children and cognitively impaired, institutionalized subjects, a population the Belmont Report’s Respect for Persons principle and the Common Rule’s additional protections for children were written in part to address.

Not the same event as the 1975 Willowbrook Consent Decree

Willowbrook is also associated with a separate, later legal case: the 1975 consent decree in New York State Association for Retarded Children v. Rockefeller, which addressed the institution’s severely inadequate living conditions — overcrowding, understaffing, and neglect, exposed publicly by a 1972 televised report — and committed the state to deinstitutionalization and community-based care for residents. That decree concerns the school’s general conditions and residents’ civil rights, not the hepatitis research specifically, and the two should not be cited interchangeably: one is a research-ethics case about a specific, deliberately designed experiment; the other is a disability-rights and institutional-conditions case about the facility as a whole.

Why it is still cited

Research-ethics and IRB training material continues to reference Willowbrook specifically because it tests a set of questions that a purely adult, competent-subject framework does not resolve: what counts as free consent when a family’s practical alternative is worse conditions elsewhere; whether a child’s inability to consent for themselves changes the ethical calculus of deliberately inducing a disease; and whether an argument from likely future harm (“they would probably get it anyway”) can justify actively causing that harm as part of a study. These are the specific reasons IRBs today apply additional scrutiny — and, for research involving children, the Common Rule’s Subpart D protections — to studies involving subjects who cannot give full informed consent on their own behalf, rather than treating parental or guardian permission alone as sufficient without further safeguards.

References

• Beecher, Henry K., “Ethics and Clinical Research,” New England Journal of Medicine 274, no. 24 (June 16, 1966): 1354-1360.
• Krugman, Saul, “The Willowbrook Hepatitis Studies Revisited: Ethical Aspects,” Reviews of Infectious Diseases 8, no. 1 (1986): 157-162.
• Rothman, David J., “Were Tuskegee and Willowbrook ‘Studies in Nature’?” Hastings Center Report 12, no. 2 (1982): 5-7.
• New York State Association for Retarded Children v. Rockefeller, 357 F. Supp. 752 (E.D.N.Y. 1973), consent decree 1975.
• National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report (April 18, 1979).